OBJECTIVE: The Child Behavior Checklist-Dysregulation Profile (CBCL/DP) identifies youth at increased risk for significant psychopathology. Although the genetic architecture and several biological correlates of the CBCL/DP have been described, little work has elucidated its underlying neurobiology. We examined the potential utility of electroencephalography (EEG), along with behavioral and cognitive assessments, in differentiating individuals based on the CBCL/DP. METHOD: Participants aged 7 to 14 years of age were categorized into 3 age- and sex-matched groups based on clinical assessment and CBCL/DP: typically developing controls without attention-deficit/hyperactivity disorder (ADHD) (n = 38), individuals with ADHD without the CBCL/DP (ADHD/DP-) (n = 38), and individuals with the CBCL/DP (CBCL/DP+) (n = 38). Groups were compared with EEG and measures of clinical phenomenology and cognition. RESULTS: ADHD/DP- and CBCL/DP+ groups had increased inattention, but the CBCL/DP+ group had increased hyperactive/impulsive symptoms, disruptive behavior, mood, and anxiety comorbidities compared with the group with ADHD alone. Cognitive profiles suggested that ADHD/DP-participants had fast impulsive responses, whereas CBCL/DP+ participants were slow and inattentive. On EEG, CBCL/DP+ had a distinct profile of attenuated δ-band and elevated α-band spectral power in the central and parietal regions compared to ADHD/DP- and controls. The low-δ/high-α profile was correlated with measures of emotion and behavior problems and not with inattentive symptomatology or cognitive measures. There were no EEG differences between the ADHD/DP- and control groups. CONCLUSIONS: An EEG/cognitive profile suggests a distinct pattern of underlying neural dysfunction with the CBCL/DP that might ultimately serve as a biosignature. Further work is required to identify potential relationships with clinically defined psychiatric disorders, particularly those of dysregulated mood.
OBJECTIVE: The Child Behavior Checklist-Dysregulation Profile (CBCL/DP) identifies youth at increased risk for significant psychopathology. Although the genetic architecture and several biological correlates of the CBCL/DP have been described, little work has elucidated its underlying neurobiology. We examined the potential utility of electroencephalography (EEG), along with behavioral and cognitive assessments, in differentiating individuals based on the CBCL/DP. METHOD:Participants aged 7 to 14 years of age were categorized into 3 age- and sex-matched groups based on clinical assessment and CBCL/DP: typically developing controls without attention-deficit/hyperactivity disorder (ADHD) (n = 38), individuals with ADHD without the CBCL/DP (ADHD/DP-) (n = 38), and individuals with the CBCL/DP (CBCL/DP+) (n = 38). Groups were compared with EEG and measures of clinical phenomenology and cognition. RESULTS:ADHD/DP- and CBCL/DP+ groups had increased inattention, but the CBCL/DP+ group had increased hyperactive/impulsive symptoms, disruptive behavior, mood, and anxiety comorbidities compared with the group with ADHD alone. Cognitive profiles suggested that ADHD/DP-participants had fast impulsive responses, whereas CBCL/DP+ participants were slow and inattentive. On EEG, CBCL/DP+ had a distinct profile of attenuated δ-band and elevated α-band spectral power in the central and parietal regions compared to ADHD/DP- and controls. The low-δ/high-α profile was correlated with measures of emotion and behavior problems and not with inattentive symptomatology or cognitive measures. There were no EEG differences between the ADHD/DP- and control groups. CONCLUSIONS: An EEG/cognitive profile suggests a distinct pattern of underlying neural dysfunction with the CBCL/DP that might ultimately serve as a biosignature. Further work is required to identify potential relationships with clinically defined psychiatric disorders, particularly those of dysregulated mood.
Authors: Ellen Leibenluft; Patricia Cohen; Tristan Gorrindo; Judith S Brook; Daniel S Pine Journal: J Child Adolesc Psychopharmacol Date: 2006-08 Impact factor: 2.576
Authors: Stephen V Faraone; Robert R Althoff; James J Hudziak; Michael Monuteaux; Joseph Biederman Journal: Bipolar Disord Date: 2005-12 Impact factor: 6.744
Authors: Robert R Althoff; David C Rettew; Stephen V Faraone; Dorret I Boomsma; James J Hudziak Journal: Biol Psychiatry Date: 2006-05-02 Impact factor: 13.382
Authors: John E Leikauf; Kristi R Griffiths; Manish Saggar; David S Hong; Simon Clarke; Daryl Efron; Tracey W Tsang; Daniel F Hermens; Michael R Kohn; Leanne M Williams Journal: Pers Med Psychiatry Date: 2017-03-18
Authors: Merelise R Ametti; Eileen T Crehan; Kerry O'Loughlin; Meghan C Schreck; Sarahjane L Dube; Alexandra S Potter; Stacey C Sigmon; Robert R Althoff Journal: J Am Acad Child Adolesc Psychiatry Date: 2022-01-22 Impact factor: 13.113
Authors: Sandra K Loo; Robert M Bilder; Alexander L Cho; Alexandra Sturm; Jennifer Cowen; Patricia Walshaw; Jennifer Levitt; Melissa Del'Homme; John Piacentini; James J McGough; James T McCracken Journal: J Am Acad Child Adolesc Psychiatry Date: 2016-05-21 Impact factor: 8.829